The alpha kinase 3 (ALPK3) gene was only recently described in connection to severe forms of pediatric cardiomyopathy, myopathic and dysmorphic skeletal features [4], while the mouse model of Alpk3-associated cardiomyopathy was described in 2012 [5]. This evidence concerns the gene ALPK3 and cardiomyopathy.